{"transactions":[{"id":704024,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-23T23:34:50.000Z","date":"2026-07-21","kind":"exercise","planned":true,"acquired":false,"shares":284800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":284800},"source":{"system":"sec-edgar","filing":"0001780851-26-000017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000017/form4.xml","form_type":"4"}},{"id":704023,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-23T23:34:50.000Z","date":"2026-07-21","kind":"sale","planned":true,"acquired":false,"shares":213702,"price":22.12,"value":4727088.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $21.90 to $22.47, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":812058,"source":{"system":"sec-edgar","filing":"0001780851-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000017/form4.xml","form_type":"4"}},{"id":704022,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-23T23:34:50.000Z","date":"2026-07-21","kind":"sale","planned":true,"acquired":false,"shares":278698,"price":21.72,"value":6053320.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $20.90 to $21.89, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1025760,"source":{"system":"sec-edgar","filing":"0001780851-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000017/form4.xml","form_type":"4"}},{"id":704021,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-23T23:34:50.000Z","date":"2026-07-21","kind":"exercise","planned":true,"acquired":true,"shares":284800,"price":6.55,"value":1865440.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026."}],"balance_after":1304458,"source":{"system":"sec-edgar","filing":"0001780851-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000017/form4.xml","form_type":"4"}},{"id":713652,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-07T22:52:49.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":146889,"price":22.45,"value":3297658.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $22.15 to $22.75, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1019658,"source":{"system":"sec-edgar","filing":"0001780851-26-000015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000015/form4.xml","form_type":"4"}},{"id":713651,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-07T22:52:49.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":239351,"price":21.74,"value":5203490.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $21.15 to $22.145, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1166547,"source":{"system":"sec-edgar","filing":"0001780851-26-000015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000015/form4.xml","form_type":"4"}},{"id":734204,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-06-18T00:11:26.000Z","date":"2026-06-16","kind":"sale","planned":true,"acquired":false,"shares":6160,"price":18.01,"value":110941.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $18.00 to $18.04, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1405898,"source":{"system":"sec-edgar","filing":"0001780851-26-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000013/form4.xml","form_type":"4"}},{"id":734203,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-06-18T00:11:26.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":17.37,"value":1737000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $17.14 to $17.96, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1412058,"source":{"system":"sec-edgar","filing":"0001780851-26-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000013/form4.xml","form_type":"4"}},{"id":810468,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-04-10T22:48:43.000Z","date":"2026-04-08","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":14.85,"value":148500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $14.65 to $15.06, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1512058,"source":{"system":"sec-edgar","filing":"0001780851-26-000011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000011/form4.xml","form_type":"4"}},{"id":843991,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-14T00:49:11.000Z","date":"2026-03-11","kind":"sale","planned":false,"acquired":false,"shares":329600,"price":13.17,"value":4340832.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance share units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":1522058,"source":{"system":"sec-edgar","filing":"0001780851-26-000007","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000007/form4.xml","form_type":"4"}},{"id":843990,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-14T00:49:11.000Z","date":"2026-03-11","kind":"sale","planned":false,"acquired":false,"shares":140666,"price":13.17,"value":1852571.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by Issuer's election under the equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":1851658,"source":{"system":"sec-edgar","filing":"0001780851-26-000007","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000007/form4.xml","form_type":"4"}},{"id":855976,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-07T00:21:34.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":709220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each performance share unit represents a contingent right to receive one share of the issuer's common stock. The performance share units were granted on March 6, 2023, with respect to the three-year period ending on March 6, 2026. The issuer certified the achievement of the performance goals on March 6, 2026.  The performance share units vested on March 6, 2026."}],"balance_after":1992324,"source":{"system":"sec-edgar","filing":"0001780851-26-000005","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000005/form4.xml","form_type":"4"}},{"id":855975,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-07T00:21:34.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":127813,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1283104,"source":{"system":"sec-edgar","filing":"0001780851-26-000005","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000005/form4.xml","form_type":"4"}},{"id":861731,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-05T00:58:30.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":14233,"price":16.52,"value":235129.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $16.55, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1155291,"source":{"system":"sec-edgar","filing":"0001780851-26-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000003/primary_doc.xml","form_type":"4"}},{"id":861730,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-05T00:58:30.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":15.72,"value":157200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.57 to $15.88, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1169524,"source":{"system":"sec-edgar","filing":"0001780851-26-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000003/primary_doc.xml","form_type":"4"}},{"id":919487,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-05T00:48:48.000Z","date":"2026-02-03","kind":"sale","planned":true,"acquired":false,"shares":8120,"price":19,"value":154280.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.56 to $19.38, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1179524,"source":{"system":"sec-edgar","filing":"0001780851-26-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000002/primary_doc.xml","form_type":"4"}},{"id":919486,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-05T00:48:48.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":34668,"price":18.6,"value":644824.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.26 to $18.88, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1187644,"source":{"system":"sec-edgar","filing":"0001780851-26-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000002/primary_doc.xml","form_type":"4"}},{"id":943296,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-09T01:17:37.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":16.44,"value":164400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.05 to $16.78, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1222312,"source":{"system":"sec-edgar","filing":"0001780851-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000001/primary_doc.xml","form_type":"4"}},{"id":979134,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-05T23:30:45.000Z","date":"2025-12-04","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":16.61,"value":166100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading plan adopted by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.45 to $16.95, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1232312,"source":{"system":"sec-edgar","filing":"0001780851-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085125000003/primary_doc.xml","form_type":"4"}},{"id":979133,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-05T23:30:45.000Z","date":"2025-12-03","kind":"sale","planned":true,"acquired":false,"shares":27212,"price":18.61,"value":506415.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading plan adopted by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.71, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1242312,"source":{"system":"sec-edgar","filing":"0001780851-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085125000003/primary_doc.xml","form_type":"4"}},{"id":1002082,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-11-13T00:30:54.000Z","date":"2025-11-10","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":14.82,"value":148200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.58 to $15.05, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1269524,"source":{"system":"sec-edgar","filing":"0001780851-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085125000002/primary_doc.xml","form_type":"4"}},{"id":1159369,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-05T21:27:53.000Z","date":"2025-05-01","kind":"exercise","planned":true,"acquired":false,"shares":68412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2024.  The option would have expired on June 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":6.32,"expiration_date":"2025-06-09","underlying":"Common Stock","underlying_shares":68412},"source":{"system":"sec-edgar","filing":"0001062993-25-008509","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000106299325008509/form4.xml","form_type":"4"}},{"id":1159368,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-05-05T21:27:53.000Z","date":"2025-05-01","kind":"sale","planned":true,"acquired":false,"shares":68412,"price":7.35,"value":502828.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2024.  The option would have expired on June 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $7.18 to 7.51, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1279524,"source":{"system":"sec-edgar","filing":"0001062993-25-008509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000106299325008509/form4.xml","form_type":"4"}},{"id":1159367,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-05-05T21:27:53.000Z","date":"2025-05-01","kind":"exercise","planned":true,"acquired":true,"shares":68412,"price":6.32,"value":432363.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2024.  The option would have expired on June 9, 2025."}],"balance_after":1347936,"source":{"system":"sec-edgar","filing":"0001062993-25-008509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000106299325008509/form4.xml","form_type":"4"}},{"id":1190985,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-26T22:48:40.000Z","date":"2025-03-24","kind":"exercise","planned":true,"acquired":false,"shares":1698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":68412,"derivative":{"exercise_price":6.32,"expiration_date":"2025-06-09","underlying":"Common Stock","underlying_shares":1698},"source":{"system":"sec-edgar","filing":"0001062993-25-006335","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000106299325006335/form4.xml","form_type":"4"}},{"id":1190984,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-26T22:48:40.000Z","date":"2025-03-24","kind":"sale","planned":true,"acquired":false,"shares":1698,"price":9,"value":15282.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $9.00 to 9.01, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1279524,"source":{"system":"sec-edgar","filing":"0001062993-25-006335","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000106299325006335/form4.xml","form_type":"4"}},{"id":1190983,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-26T22:48:40.000Z","date":"2025-03-24","kind":"exercise","planned":true,"acquired":true,"shares":1698,"price":6.32,"value":10731.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2024."}],"balance_after":1281222,"source":{"system":"sec-edgar","filing":"0001062993-25-006335","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000106299325006335/form4.xml","form_type":"4"}},{"id":1219670,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-07T00:18:40.000Z","date":"2025-03-05","kind":"sale","planned":false,"acquired":false,"shares":56053,"price":6.99,"value":391810.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by Issuer's election under the equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":1279524,"source":{"system":"sec-edgar","filing":"0001062993-25-004810","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000106299325004810/form4.xml","form_type":"4"}},{"id":1219669,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-07T00:18:40.000Z","date":"2025-03-05","kind":"sale","planned":false,"acquired":false,"shares":40603,"price":6.98,"value":283408.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by Issuer's election under the equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":1335577,"source":{"system":"sec-edgar","filing":"0001062993-25-004810","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000106299325004810/form4.xml","form_type":"4"}},{"id":1219668,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-07T00:18:40.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":355000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1376180,"source":{"system":"sec-edgar","filing":"0001062993-25-004810","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000106299325004810/form4.xml","form_type":"4"}},{"id":1591886,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-03-07T00:41:08.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":354610,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1021180,"source":{"system":"sec-edgar","filing":"0001062993-24-005760","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000106299324005760/form4.xml","form_type":"4"}},{"id":1963397,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-03-09T01:00:54.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":354610,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":666570,"source":{"system":"sec-edgar","filing":"0001062993-23-006322","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000106299323006322/form4.xml","form_type":"4"}},{"id":2344774,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T02:00:41.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":617792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":617792,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":617792},"source":{"system":"sec-edgar","filing":"0001209191-22-017394","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919122017394/doc4.xml","form_type":"4"}},{"id":2344773,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-09T02:00:41.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":4517,"price":12.01,"value":54249.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":311960,"source":{"system":"sec-edgar","filing":"0001209191-22-017394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919122017394/doc4.xml","form_type":"4"}},{"id":2344772,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-09T02:00:41.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":247117,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":316477,"source":{"system":"sec-edgar","filing":"0001209191-22-017394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919122017394/doc4.xml","form_type":"4"}},{"id":2503042,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-19T21:59:20.000Z","date":"2021-11-18","kind":"exercise","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":284800,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0001209191-21-065839","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121065839/doc4.xml","form_type":"4"}},{"id":2503041,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-19T21:59:20.000Z","date":"2021-11-17","kind":"exercise","acquired":false,"shares":3700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":285100,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":3700},"source":{"system":"sec-edgar","filing":"0001209191-21-065839","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121065839/doc4.xml","form_type":"4"}},{"id":2503040,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-19T21:59:20.000Z","date":"2021-11-18","kind":"sale","acquired":false,"shares":300,"price":31.36,"value":9408.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $31.00 to 31.76, inclusive."}],"balance_after":69360,"source":{"system":"sec-edgar","filing":"0001209191-21-065839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121065839/doc4.xml","form_type":"4"}},{"id":2503039,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-19T21:59:20.000Z","date":"2021-11-18","kind":"exercise","acquired":true,"shares":300,"price":6.55,"value":1965.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021."}],"balance_after":69660,"source":{"system":"sec-edgar","filing":"0001209191-21-065839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121065839/doc4.xml","form_type":"4"}},{"id":2503038,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-19T21:59:20.000Z","date":"2021-11-17","kind":"sale","acquired":false,"shares":3700,"price":32.05,"value":118585.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $31.45 to 32.36, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":69360,"source":{"system":"sec-edgar","filing":"0001209191-21-065839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121065839/doc4.xml","form_type":"4"}},{"id":2503037,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-19T21:59:20.000Z","date":"2021-11-17","kind":"exercise","acquired":true,"shares":3700,"price":6.55,"value":24235.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021."}],"balance_after":73060,"source":{"system":"sec-edgar","filing":"0001209191-21-065839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121065839/doc4.xml","form_type":"4"}},{"id":2537396,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-22T01:00:17.000Z","date":"2021-10-21","kind":"exercise","acquired":false,"shares":3700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":288800,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":3700},"source":{"system":"sec-edgar","filing":"0001209191-21-061319","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121061319/doc4.xml","form_type":"4"}},{"id":2537395,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-22T01:00:17.000Z","date":"2021-10-20","kind":"exercise","acquired":false,"shares":3700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":292500,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":3700},"source":{"system":"sec-edgar","filing":"0001209191-21-061319","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121061319/doc4.xml","form_type":"4"}},{"id":2537394,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-22T01:00:17.000Z","date":"2021-10-19","kind":"exercise","acquired":false,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":296200,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":3800},"source":{"system":"sec-edgar","filing":"0001209191-21-061319","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121061319/doc4.xml","form_type":"4"}},{"id":2537393,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-22T01:00:17.000Z","date":"2021-10-21","kind":"sale","acquired":false,"shares":3700,"price":33.73,"value":124801.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $33.08 to 33.99, inclusive."}],"balance_after":69360,"source":{"system":"sec-edgar","filing":"0001209191-21-061319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121061319/doc4.xml","form_type":"4"}},{"id":2537392,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-22T01:00:17.000Z","date":"2021-10-21","kind":"exercise","acquired":true,"shares":3700,"price":6.55,"value":24235.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021."}],"balance_after":73060,"source":{"system":"sec-edgar","filing":"0001209191-21-061319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121061319/doc4.xml","form_type":"4"}},{"id":2537391,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-22T01:00:17.000Z","date":"2021-10-20","kind":"sale","acquired":false,"shares":3700,"price":33.71,"value":124727.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $33.08 to 34.01, inclusive."}],"balance_after":69360,"source":{"system":"sec-edgar","filing":"0001209191-21-061319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121061319/doc4.xml","form_type":"4"}},{"id":2537390,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-22T01:00:17.000Z","date":"2021-10-20","kind":"exercise","acquired":true,"shares":3700,"price":6.55,"value":24235.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021."}],"balance_after":73060,"source":{"system":"sec-edgar","filing":"0001209191-21-061319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121061319/doc4.xml","form_type":"4"}},{"id":2537389,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-22T01:00:17.000Z","date":"2021-10-19","kind":"sale","acquired":false,"shares":3500,"price":33.76,"value":118160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $33.53 to 34.00, inclusive."}],"balance_after":69360,"source":{"system":"sec-edgar","filing":"0001209191-21-061319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121061319/doc4.xml","form_type":"4"}},{"id":2537388,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-22T01:00:17.000Z","date":"2021-10-19","kind":"sale","acquired":false,"shares":300,"price":32.91,"value":9873.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $32.80 to 32.99, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":72860,"source":{"system":"sec-edgar","filing":"0001209191-21-061319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121061319/doc4.xml","form_type":"4"}},{"id":2537387,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-22T01:00:17.000Z","date":"2021-10-19","kind":"exercise","acquired":true,"shares":3800,"price":6.55,"value":24890.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021."}],"balance_after":73160,"source":{"system":"sec-edgar","filing":"0001209191-21-061319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121061319/doc4.xml","form_type":"4"}},{"id":2545551,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-08T23:00:15.000Z","date":"2021-10-08","kind":"exercise","acquired":false,"shares":3895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable."}],"balance_after":70110,"derivative":{"exercise_price":6.32,"expiration_date":"2025-06-09","underlying":"Common Stock","underlying_shares":3895},"source":{"system":"sec-edgar","filing":"0001209191-21-060115","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121060115/doc4.xml","form_type":"4"}},{"id":2545550,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-08T23:00:15.000Z","date":"2021-10-07","kind":"exercise","acquired":false,"shares":3895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable."}],"balance_after":74005,"derivative":{"exercise_price":6.32,"expiration_date":"2025-06-09","underlying":"Common Stock","underlying_shares":3895},"source":{"system":"sec-edgar","filing":"0001209191-21-060115","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121060115/doc4.xml","form_type":"4"}},{"id":2545549,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-08T23:00:15.000Z","date":"2021-10-06","kind":"exercise","acquired":false,"shares":3895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable."}],"balance_after":77900,"derivative":{"exercise_price":6.32,"expiration_date":"2025-06-09","underlying":"Common Stock","underlying_shares":3895},"source":{"system":"sec-edgar","filing":"0001209191-21-060115","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121060115/doc4.xml","form_type":"4"}},{"id":2545548,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-08T23:00:15.000Z","date":"2021-10-08","kind":"sale","acquired":false,"shares":3895,"price":32.96,"value":128379.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $32.68 to 33.33, inclusive."}],"balance_after":69360,"source":{"system":"sec-edgar","filing":"0001209191-21-060115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121060115/doc4.xml","form_type":"4"}},{"id":2545547,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-08T23:00:15.000Z","date":"2021-10-08","kind":"exercise","acquired":true,"shares":3895,"price":6.32,"value":24616.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."}],"balance_after":73255,"source":{"system":"sec-edgar","filing":"0001209191-21-060115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121060115/doc4.xml","form_type":"4"}},{"id":2545546,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-08T23:00:15.000Z","date":"2021-10-07","kind":"sale","acquired":false,"shares":3695,"price":33.68,"value":124447.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $33.07 to 33.93, inclusive."}],"balance_after":69360,"source":{"system":"sec-edgar","filing":"0001209191-21-060115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121060115/doc4.xml","form_type":"4"}},{"id":2545545,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-08T23:00:15.000Z","date":"2021-10-07","kind":"sale","acquired":false,"shares":200,"price":32.5,"value":6500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $32.21 to 32.80, inclusive."}],"balance_after":73055,"source":{"system":"sec-edgar","filing":"0001209191-21-060115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121060115/doc4.xml","form_type":"4"}},{"id":2545544,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-08T23:00:15.000Z","date":"2021-10-07","kind":"exercise","acquired":true,"shares":3895,"price":6.32,"value":24616.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."}],"balance_after":73255,"source":{"system":"sec-edgar","filing":"0001209191-21-060115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121060115/doc4.xml","form_type":"4"}},{"id":2545543,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-08T23:00:15.000Z","date":"2021-10-06","kind":"sale","acquired":false,"shares":3895,"price":32.27,"value":125691.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $31.82 to 32.78, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":69360,"source":{"system":"sec-edgar","filing":"0001209191-21-060115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121060115/doc4.xml","form_type":"4"}},{"id":2545542,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-08T23:00:15.000Z","date":"2021-10-06","kind":"exercise","acquired":true,"shares":3895,"price":6.32,"value":24616.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."}],"balance_after":73255,"source":{"system":"sec-edgar","filing":"0001209191-21-060115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121060115/doc4.xml","form_type":"4"}},{"id":2569502,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-15T23:51:04.000Z","date":"2021-09-15","kind":"exercise","acquired":false,"shares":3895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option is fully vested and exercisable."}],"balance_after":81795,"derivative":{"exercise_price":6.32,"expiration_date":"2025-06-09","underlying":"Common Stock","underlying_shares":3895},"source":{"system":"sec-edgar","filing":"0001209191-21-056261","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121056261/doc4.xml","form_type":"4"}},{"id":2569501,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-15T23:51:04.000Z","date":"2021-09-14","kind":"exercise","acquired":false,"shares":3895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option is fully vested and exercisable."}],"balance_after":85690,"derivative":{"exercise_price":6.32,"expiration_date":"2025-06-09","underlying":"Common Stock","underlying_shares":3895},"source":{"system":"sec-edgar","filing":"0001209191-21-056261","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121056261/doc4.xml","form_type":"4"}},{"id":2569500,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-15T23:51:04.000Z","date":"2021-09-13","kind":"exercise","acquired":false,"shares":3895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option is fully vested and exercisable."}],"balance_after":89585,"derivative":{"exercise_price":6.32,"expiration_date":"2025-06-09","underlying":"Common Stock","underlying_shares":3895},"source":{"system":"sec-edgar","filing":"0001209191-21-056261","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121056261/doc4.xml","form_type":"4"}},{"id":2569499,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-15T23:51:04.000Z","date":"2021-09-15","kind":"sale","acquired":false,"shares":900,"price":37.23,"value":33507.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $37.03 to 37.47, inclusive."}],"balance_after":69360,"source":{"system":"sec-edgar","filing":"0001209191-21-056261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121056261/doc4.xml","form_type":"4"}},{"id":2569498,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-15T23:51:04.000Z","date":"2021-09-15","kind":"sale","acquired":false,"shares":2995,"price":36.52,"value":109377.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $36.01 to 36.84, inclusive."}],"balance_after":70260,"source":{"system":"sec-edgar","filing":"0001209191-21-056261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121056261/doc4.xml","form_type":"4"}},{"id":2569497,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-15T23:51:04.000Z","date":"2021-09-15","kind":"exercise","acquired":true,"shares":3895,"price":6.32,"value":24616.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."}],"balance_after":73255,"source":{"system":"sec-edgar","filing":"0001209191-21-056261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121056261/doc4.xml","form_type":"4"}},{"id":2569496,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-15T23:51:04.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":1100,"price":37.36,"value":41096.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $37.12 to 37.68, inclusive."}],"balance_after":69360,"source":{"system":"sec-edgar","filing":"0001209191-21-056261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121056261/doc4.xml","form_type":"4"}},{"id":2569495,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-15T23:51:04.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":2795,"price":36.49,"value":101989.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $36.14 to 36.98, inclusive."}],"balance_after":70460,"source":{"system":"sec-edgar","filing":"0001209191-21-056261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121056261/doc4.xml","form_type":"4"}},{"id":2569494,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-15T23:51:04.000Z","date":"2021-09-14","kind":"exercise","acquired":true,"shares":3895,"price":6.32,"value":24616.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."}],"balance_after":73255,"source":{"system":"sec-edgar","filing":"0001209191-21-056261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121056261/doc4.xml","form_type":"4"}},{"id":2569493,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-15T23:51:04.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":900,"price":37.89,"value":34101.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $37.72 to 38.10, inclusive."}],"balance_after":69360,"source":{"system":"sec-edgar","filing":"0001209191-21-056261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121056261/doc4.xml","form_type":"4"}},{"id":2569492,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-15T23:51:04.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":2995,"price":37.39,"value":111983.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $36.72 to 37.68, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":70260,"source":{"system":"sec-edgar","filing":"0001209191-21-056261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121056261/doc4.xml","form_type":"4"}},{"id":2569491,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-15T23:51:04.000Z","date":"2021-09-13","kind":"exercise","acquired":true,"shares":3895,"price":6.32,"value":24616.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."}],"balance_after":73255,"source":{"system":"sec-edgar","filing":"0001209191-21-056261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121056261/doc4.xml","form_type":"4"}},{"id":2588427,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-28T01:00:29.000Z","date":"2021-08-27","kind":"exercise","acquired":false,"shares":3895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable."}],"balance_after":93480,"derivative":{"exercise_price":6.32,"expiration_date":"2025-06-09","underlying":"Common Stock","underlying_shares":3895},"source":{"system":"sec-edgar","filing":"0001209191-21-053766","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121053766/doc4.xml","form_type":"4"}},{"id":2588426,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-28T01:00:29.000Z","date":"2021-08-26","kind":"exercise","acquired":false,"shares":3895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable."}],"balance_after":97375,"derivative":{"exercise_price":6.32,"expiration_date":"2025-06-09","underlying":"Common Stock","underlying_shares":3895},"source":{"system":"sec-edgar","filing":"0001209191-21-053766","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121053766/doc4.xml","form_type":"4"}},{"id":2588425,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-28T01:00:29.000Z","date":"2021-08-25","kind":"exercise","acquired":false,"shares":3895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable."}],"balance_after":101270,"derivative":{"exercise_price":6.32,"expiration_date":"2025-06-09","underlying":"Common Stock","underlying_shares":3895},"source":{"system":"sec-edgar","filing":"0001209191-21-053766","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121053766/doc4.xml","form_type":"4"}},{"id":2588424,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-28T01:00:29.000Z","date":"2021-08-27","kind":"sale","acquired":false,"shares":2934,"price":34.97,"value":102601.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $34.67 to 35.26, inclusive."}],"balance_after":69360,"source":{"system":"sec-edgar","filing":"0001209191-21-053766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121053766/doc4.xml","form_type":"4"}},{"id":2588423,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-28T01:00:29.000Z","date":"2021-08-27","kind":"sale","acquired":false,"shares":961,"price":34.18,"value":32846.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $33.66 to 34.63, inclusive."}],"balance_after":72294,"source":{"system":"sec-edgar","filing":"0001209191-21-053766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121053766/doc4.xml","form_type":"4"}},{"id":2588422,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-28T01:00:29.000Z","date":"2021-08-27","kind":"exercise","acquired":true,"shares":3895,"price":6.32,"value":24616.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."}],"balance_after":73255,"source":{"system":"sec-edgar","filing":"0001209191-21-053766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121053766/doc4.xml","form_type":"4"}},{"id":2588421,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-28T01:00:29.000Z","date":"2021-08-26","kind":"sale","acquired":false,"shares":3895,"price":33.89,"value":132001.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $33.57 to 34.49, inclusive."}],"balance_after":69360,"source":{"system":"sec-edgar","filing":"0001209191-21-053766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121053766/doc4.xml","form_type":"4"}},{"id":2588420,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-28T01:00:29.000Z","date":"2021-08-26","kind":"exercise","acquired":true,"shares":3895,"price":6.32,"value":24616.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."}],"balance_after":73255,"source":{"system":"sec-edgar","filing":"0001209191-21-053766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121053766/doc4.xml","form_type":"4"}},{"id":2588419,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-28T01:00:29.000Z","date":"2021-08-25","kind":"sale","acquired":false,"shares":3895,"price":34.09,"value":132780.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $33.61 to 34.39, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":69360,"source":{"system":"sec-edgar","filing":"0001209191-21-053766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121053766/doc4.xml","form_type":"4"}},{"id":2588418,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-28T01:00:29.000Z","date":"2021-08-25","kind":"exercise","acquired":true,"shares":3895,"price":6.32,"value":24616.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."}],"balance_after":73255,"source":{"system":"sec-edgar","filing":"0001209191-21-053766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121053766/doc4.xml","form_type":"4"}},{"id":2628334,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-22T01:00:19.000Z","date":"2021-07-21","kind":"exercise","acquired":false,"shares":3895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option is fully vested and exercisable."}],"balance_after":105165,"derivative":{"exercise_price":6.32,"expiration_date":"2025-06-09","underlying":"Common Stock","underlying_shares":3895},"source":{"system":"sec-edgar","filing":"0001209191-21-047649","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121047649/doc4.xml","form_type":"4"}},{"id":2628333,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-22T01:00:19.000Z","date":"2021-07-20","kind":"exercise","acquired":false,"shares":3895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option is fully vested and exercisable."}],"balance_after":109060,"derivative":{"exercise_price":6.32,"expiration_date":"2025-06-09","underlying":"Common Stock","underlying_shares":3895},"source":{"system":"sec-edgar","filing":"0001209191-21-047649","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121047649/doc4.xml","form_type":"4"}},{"id":2628332,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-22T01:00:19.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":3895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option is fully vested and exercisable."}],"balance_after":112955,"derivative":{"exercise_price":6.32,"expiration_date":"2025-06-09","underlying":"Common Stock","underlying_shares":3895},"source":{"system":"sec-edgar","filing":"0001209191-21-047649","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121047649/doc4.xml","form_type":"4"}},{"id":2628331,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-22T01:00:19.000Z","date":"2021-07-21","kind":"sale","acquired":false,"shares":2495,"price":38.11,"value":95084.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $37.82 to 38.36, inclusive."}],"balance_after":69360,"source":{"system":"sec-edgar","filing":"0001209191-21-047649","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121047649/doc4.xml","form_type":"4"}},{"id":2628330,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-22T01:00:19.000Z","date":"2021-07-21","kind":"sale","acquired":false,"shares":1400,"price":37.29,"value":52206.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $36.76 to 37.65, inclusive."}],"balance_after":71855,"source":{"system":"sec-edgar","filing":"0001209191-21-047649","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121047649/doc4.xml","form_type":"4"}},{"id":2628329,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-22T01:00:19.000Z","date":"2021-07-21","kind":"exercise","acquired":true,"shares":3895,"price":6.32,"value":24616.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."}],"balance_after":73255,"source":{"system":"sec-edgar","filing":"0001209191-21-047649","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121047649/doc4.xml","form_type":"4"}},{"id":2628328,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-22T01:00:19.000Z","date":"2021-07-20","kind":"sale","acquired":false,"shares":2595,"price":37.82,"value":98142.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $37.41 to 38.13, inclusive."}],"balance_after":69360,"source":{"system":"sec-edgar","filing":"0001209191-21-047649","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121047649/doc4.xml","form_type":"4"}},{"id":2628327,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-22T01:00:19.000Z","date":"2021-07-20","kind":"sale","acquired":false,"shares":1300,"price":36.81,"value":47853.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $36.36 to 37.18, inclusive."}],"balance_after":71955,"source":{"system":"sec-edgar","filing":"0001209191-21-047649","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121047649/doc4.xml","form_type":"4"}},{"id":2628326,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-22T01:00:19.000Z","date":"2021-07-20","kind":"exercise","acquired":true,"shares":3895,"price":6.32,"value":24616.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."}],"balance_after":73255,"source":{"system":"sec-edgar","filing":"0001209191-21-047649","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121047649/doc4.xml","form_type":"4"}},{"id":2628325,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-22T01:00:19.000Z","date":"2021-07-19","kind":"sale","acquired":false,"shares":2622,"price":37.33,"value":97879.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $37.00 to 37.85, inclusive."}],"balance_after":69360,"source":{"system":"sec-edgar","filing":"0001209191-21-047649","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121047649/doc4.xml","form_type":"4"}},{"id":2628324,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-22T01:00:19.000Z","date":"2021-07-19","kind":"sale","acquired":false,"shares":1273,"price":36.7,"value":46719.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $36.08 to 36.96, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":71982,"source":{"system":"sec-edgar","filing":"0001209191-21-047649","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121047649/doc4.xml","form_type":"4"}},{"id":2628323,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-07-22T01:00:19.000Z","date":"2021-07-19","kind":"exercise","acquired":true,"shares":3895,"price":6.32,"value":24616.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."}],"balance_after":73255,"source":{"system":"sec-edgar","filing":"0001209191-21-047649","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121047649/doc4.xml","form_type":"4"}},{"id":2672208,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-12T01:00:26.000Z","date":"2021-05-06","kind":"exercise","acquired":false,"shares":3895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":128535,"derivative":{"exercise_price":6.32,"expiration_date":"2025-06-09","underlying":"Common Stock","underlying_shares":3895},"source":{"system":"sec-edgar","filing":"0001209191-21-040099","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121040099/doc4a.xml","form_type":"4/A","original_submission_date":"2021-05-07"}},{"id":2672207,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-12T01:00:26.000Z","date":"2021-05-05","kind":"exercise","acquired":false,"shares":3895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":132430,"derivative":{"exercise_price":6.32,"expiration_date":"2025-06-09","underlying":"Common Stock","underlying_shares":3895},"source":{"system":"sec-edgar","filing":"0001209191-21-040099","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121040099/doc4a.xml","form_type":"4/A","original_submission_date":"2021-05-07"}},{"id":2672206,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-12T01:00:26.000Z","date":"2021-05-06","kind":"sale","acquired":false,"shares":847,"price":36.38,"value":30813.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $35.99 to 36.70, inclusive."}],"balance_after":69360,"source":{"system":"sec-edgar","filing":"0001209191-21-040099","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121040099/doc4a.xml","form_type":"4/A","original_submission_date":"2021-05-07"}},{"id":2672205,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-12T01:00:26.000Z","date":"2021-05-06","kind":"sale","acquired":false,"shares":3048,"price":35.51,"value":108234.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $34.97 to 35.95, inclusive."}],"balance_after":70207,"source":{"system":"sec-edgar","filing":"0001209191-21-040099","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121040099/doc4a.xml","form_type":"4/A","original_submission_date":"2021-05-07"}},{"id":2672204,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-12T01:00:26.000Z","date":"2021-05-06","kind":"exercise","acquired":true,"shares":3895,"price":6.32,"value":24616.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020."}],"balance_after":73255,"source":{"system":"sec-edgar","filing":"0001209191-21-040099","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000120919121040099/doc4a.xml","form_type":"4/A","original_submission_date":"2021-05-07"}}],"next_cursor":"2021-06-12T01:00:26.000000Z,2672204"}